Albany, NY -- (SBWire) -- 05/16/2019 --Global Perfusion Systems Market: Snapshot

The overall revenue in the global perfusion systems market is estimated to breach a billion mark by the end of 2022, which is a reflection of a number of factors such as increasing demand for organ transplantation as a result of increases geriatric population and lifestyle inflicted cardiovascular and respiratory diseases, recent technological advancements, and increased number of awareness programs run by governments and NGOs to promote organ donation. On the other hand, high cost of devices and consequently extremely high cost of organ transplant that takes it out of range of various prospect patients and the dearth of organ donation are some of the factors challenging the global perfusion systems market. Nevertheless, growing preference of continuous manufacturing and prospering pharmaceutical research in emerging markets are expected to open new opportunities for the vendors operating in this market.

Obtain Report Details @

https://www.transparencymarketresearch.com/perfusion-systems-market.html

The demand in the global perfusion systems market is project to increment at a CAGR of 3.4% during the forecast period of 2017 to 2022, when the market will be worth US$1,164.1 mn, substantially up from its evaluated valuation of US$985.6 mn in 2017.

Cardiopulmonary Perfusion Most Profitable Product Segment

On the basis of product type, the global perfusion systems market has been segmented into cardiopulmonary perfusion, cell perfusion, and ex vivo organ perfusion. In 2017, cardiopulmonary perfusion systems market produced a demand worth of US$537.9 mn and represented 54.6% of the overall demand in the global perfusion systems market. The cardiopulmonary perfusion systems can be further sub-segmented into heart-lung machines, perfusion pumps, cannulas, oxygenators, monitoring systems, and others. During the forecast period of 2017 to 2022, this segment is estimated to expand at a CAGR of 3.5% to reach a valuation of US$637.5 mn, which will represent 54.8% of the total demand in this market. The cardiopulmonary perfusion systems segment is producing US$19.9 mn annually over the course of the forecast period, and this absolute growth is larger than any other segment.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=28361

Based on end-users, the global perfusion systems market has been bifurcated into hospitals, ambulatory surgical centers (ASCs), specialty clinics, and others. Currently, hospitals account for the maximum share of the demand and will continue to dominate throughout the forecast period. However, ASCs are incrementing the demand in various developed regions, whereas specialty clinics are mushrooming in emerging economies.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28361

About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website:www.transparencymarketresearch.com